Use of the CANDIVAC cps. yeast plant lyophilisate in females with recurrent vulvovaginal candidiasis: clinical study results

1 Centrum ambulantní gynekologie o primární peče, Brno, Czechy
2 Gynekologicko-porodnická klinika MU a FN, Brno, Czechy
3 Gynekologická ambulanse, Praga, Czechy
4 Gynekologická ambulanse, Kolín, Czechy
5 Gynekologická ambulanse, Pilzno, Czechy
Adres do korespondencji: Doc. MUDr Vít Unzeitig. CSc., Centrum ambulantní gynekologie a primární peče, Brno, Czechy,; Gynekologicko-porodnická klinika LF MU a FN, Brno, Czechy,; e-mail:

Pediatr Med rodz Vol 9 Numer 4, p. 404–407

The problem of the relapsing vulvovaginal candidiasis is not due to the infection with a new yeast plant, it lies in susceptibility to being infected by one’s own yeast plant. Help can be provided through immunomodulation by CANDIVAC cps. yeast lysates, which in a dose of 10 tablets per month for a period of six months brought a statistically significant reduction in the relapse occurrence as well as intensity of patients’ subjective complaints. There is no direct relation between the amount of yeast in the vagina, the quality of lactobacillary grading and the degree of seriousness of clinical symptoms.

Keywords: recurrent vulvovaginal candidiasis, immunomodulation therapy, lyofilisates, relapse of vulvovaginal candidiasis